Most recent papers with the keyword Lymphoma | Read by QxMD
... or combined modality treatment consisting of a brief chemotherapy with 2 cycles of ABVD (doxorubicin, bleomycin, vinblastine, ... and second-line therapy of Hodgkin lymphoma. Preliminary data show that brentuximab vedotin alone is not adequate therapy for ... "primary prevention of cancer" (heart or cardiac or cardio*) AND arrest -"American Heart Association" ... During the past 10 years improvements in survival have been achieved with the implementation of anti-CD20 immunotherapy and ...https://www.readbyqxmd.com/keyword/958
Combining radiation and immunotherapy | OncologyPRO
Multi-modality and multi-drug cancer therapy. Topics. Personalised Medicine. Translational Research. Cancer Immunology and ... Cancer Immunology and Immunotherapy. Get information on recent advances in cancer immunology & immunotherapy and keep up with ... Anti-Cancer Agents and Biological Therapy. Find the essential information, user-friendly publications and resources presenting ... Cancer in Medical Journals. Collection of links to the latest cancer related articles in top medical journals: Annals of ...http://oncologypro.esmo.org/Topics/Cancer-Immunology-and-Immunotherapy/Combining-radiation-and-immunotherapy
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy | Cancer Research
... combining radiotherapy and immunotherapy can be done following a variety of different modalities. Determining the exact ... T-cell responses to survivin in cancer patients undergoing radiation therapy. Clin Cancer Res 2008;14:4883-90. ... Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013;105:256-65. ... Combining radiation and immunotherapy: a new systemic. Cancer Immunol Res 2014;2:831-8. ...http://cancerres.aacrjournals.org/content/76/17/4931.long
Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved...
Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunol Immunother 2008; 57: 1523-1529.. *CrossRef ... Combining vaccines with conventional therapies for cancer. Update Cancer Ther 2007; 2: 33-39.. *CrossRef , ... Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 2004; 4: 11-22.. *CrossRef , ... Next waves in cancer immunotherapy - Report on the 12th annual meeting of the Association for Cancer Immunotherapy, Human ...http://onlinelibrary.wiley.com/doi/10.1002/jgm.2605/full
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer - Full Text View -...
Stage IV or IIIB (disease that is not eligible for combined modality chemotherapy and radiation) ... Prior chemotherapy, immunotherapy or biologic therapy for metastatic NSCLC. *Up to one prior adjuvant or neoadjuvant ... Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer. This study has been ... carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. ...https://clinicaltrials.gov/ct2/show/NCT00088556
Cancer | definition of cancer by Medical dictionary
... cancer explanation free. What is cancer? Meaning of cancer medical term. What does cancer mean? ... Looking for online definition of cancer in the Medical Dictionary? ... Surgery, chemotherapy, immunotherapy, hormone therapy, radiation therapy, and combined-modality therapies often are effective ... Regional cancer, Residual cancer, Scar cancer, Second cancer, Skin cancer, Small cell lung cancer, Solid cancer, Solid cancer, ...http://medical-dictionary.thefreedictionary.com/Cancer
Eradicating HIV-1 infection: seeking to clear a persistent pathogen - Review
Synergy has often been described as a combined effect that is greater than the sum of the effect of two separate modalities. ... Combination cancer chemotherapy and immunotherapy have only recently been successfully used after many years of intense ... do host-targeted anti-latency therapies affect such adjunctive therapies?. Clearing persistently infected cells. The induction ... This effort should be linked to studies of the disruption of latency, as the modalities are likely to be combined. Therefore, ...http://www.natap.org/2014/HIV/103114_02.htm
An immunotherapy is any therapy that trains a patient's own immune system to detect and destroy cancer cells. Many of our ... making UMGCCC one of the region's leaders in this growing area of cancer treatment research.,/p, ... p,UMGCCC gives patients access to many different forms of immunotherapy. ... physicians are principal investigators in immunotherapy clinical trials, ...https://www.umms.org/umgccc/cancer-services/cancer-care/research-clinical-trials/clinical-trials/cancer-immunotherapy
Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer
Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a hig... ... radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of ... CONFORMAL RADIOTHERAPY that combines several intensity-modulated beams to provide improved dose homogeneity and highly ... Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer. 2014-08-27 03:19:43 , BioPortfolio ...https://www.bioportfolio.com/resources/trial/73273/Radiation-Therapy-in-Treating-Patients-Receiving-Hormone-Therapy-for-Prostate-Cancer.html
Gordon Li, MD | Stanford Medicine Profiles
Optimally combining radiation with immunotherapy may be the key to unlocking the potential of both therapies given the evidence ... The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers Patel, M. A., Kim, J. E., Ruzevick ... Immunotherapy is an attractive new treatment modality given its potential for exquisite specificity and its favorable side ... Therapeutic immune approaches include cytokine therapy, passive immunotherapy, and active immunotherapy. Cytokine therapy ...https://med.stanford.edu/profiles/gordon-li
FDA Review in Journal for ImmunoTherapy of Cancer Offers New Insights into Cancer Immunotherapy Product Development & Clinical ...
ImmunoTherapy,of,Cancer,Offers,New,Insights,into,Cancer,Immunotherapy,Product,Development,&,Clinical,Evaluation,biological, ... appears in an extensive new review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. ... A picture of what the FDA is looking for in cancer immunotherapy product development ... As mechanisms of tumor immune escape have become better defined, approaches that combine two or more modalities to overcome ...http://www.bio-medicine.org/biology-technology-1/FDA-Review-in-Journal-for-ImmunoTherapy-of-Cancer-Offers-New-Insights-into-Cancer-Immunotherapy-Product-Development--26amp-3B-Clinical-Evaluation-26356-1/
Regulation of cancer by therapeutic vaccination and dietary bio-modulation involving organ-specific mitochondria on...
Cancer therapy should aim to prevent recurrent disease. Surgery and toxic treatments remove only symptoms associated with ... Article Regulation of cancer by therapeutic vaccination and dietary bio-modulation involving organ-specific mitochondria. ... Our findings indicate that combined immunological and biological modality called 'bio-immunotherapy' is an effective approach ... Keywords: biological cancer therapy, autologous cancer vaccine, mitochondrial gene regulation, cancer aetiology, metabolic ...https://www.environmental-expert.com/articles/regulation-of-cancer-by-therapeutic-vaccination-and-dietary-bio-modulation-involving-organ-specific--80684
Cancer research - Wikipedia
... hormone therapy, immunotherapy and combined treatment modalities such as chemo-radiotherapy. Starting in the mid-1990s, the ... such as cancer immunotherapy and gene therapy. Cancer research has been ongoing for centuries. Early research focused on the ... https://www.cancer.org/cancer/cancer-basics/history-of-cancer/cancer-causes-theories-throughout-history.html https://www.ncbi. ... and new targets for cancer therapies. As the Cancer Genome Project stated in a 2004 review article, "a central aim of cancer ...https://en.wikipedia.org/wiki/Cancer_research
How Immunotherapy Is Revolutionizing Cancer Care - The ASCO Post
The idea of combining different modalities in different molecules is very exciting, and hopefully, it will be very fruitful for ... Today, immunotherapy for the treatment of a variety of cancers is rapidly evolving from therapies that nonspecifically ... It is also logical to start using combination immunotherapies in the treatment of cancer. For example, CAR-T-cell therapy ... Potential of Immunotherapy. How is immunotherapy already changing clinical practice in the treatment of a variety of cancers, ...http://www.ascopost.com/issues/may-25-2016/how-immunotherapy-is-revolutionizing-cancer-care/
Sir Gustav Nossal, immunologist | Australian Academy of Science
... a cancer therapy modality will come forward.. Everything we've learnt about cancer in these last 50 years of very frontal study ... by immunotherapy? The jury isn't yet in on this one, I think, but I would look more to a future which combines cellular therapy ... The big question is whether this will include the common cancers. Most of the triumphs in cancer therapy in the recent past ... The continuing fight against cancer. We're facing an extremely interesting future in regard to the cancer problem too, because ...https://www.science.org.au/learning/general-audience/history/interviews-australian-scientists/sir-gustav-nossal-immunologist-2
Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer - The...
Treatment for inflammatory breast cancer requires multimodality therapy, with chemotherapy, mastectomy, and radiation therapy ... "So what can we do to improve on this modality of treatment, and what can we add? First of all, we can certainly look at the ... Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer. By ... Combining Molecular-Driven Approach and Immunotherapy to Improve Treatment for Patients With Inflammatory Breast Cancer ...http://www.ascopost.com/issues/december-10-2015/combining-molecular-driven-approach-and-immunotherapy-to-improve-treatment-for-patients-with-inflammatory-breast-cancer/
Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and...
Patients who are initially rendered NED by combined modality therapy but exhibit disease progression prior to initiation of ... Cancer-testis (CT) antigens have emerged as attractive targets for cancer immunotherapy. Whereas lung and esophageal cancers, ... Mesolthelioma Esophageal Cancer Lung Cancer Thoracic Sarcomas Thymoma Drug: Celebrex Biological: Tumor cell vaccine Phase 1 ... De novo induction of a cancer/testis antigen by 5-aza-2'-deoxycytidine augments adoptive immunotherapy in a murine tumor model ...https://clinicaltrials.gov/ct2/show/NCT01258868?term=pleural+plaque+OR+pleural+effusion+OR+asbestosis+OR+mesothelioma&recr=Open&fund=01&rank=6
Synergism of Epidermal Growth Factor Receptor-Targeted Immunotherapy With Photodynamic Treatment of Ovarian Cancer In Vivo :...
... and photodynamic therapy (PDT), a mechanistically distinct photochemistry-based modality that is effective against chemo- and ... We examined the efficacy of a treatment regimen that combines immunotherapy to block the activity of epidermal growth factor ... We examined the efficacy of a treatment regimen that combines immunotherapy to block the activity of epidermal growth factor ... and photodynamic therapy (PDT), a mechanistically distinct photochemistry-based modality that is effective against chemo- and ...http://oxfordindex.oup.com/view/10.1093/jnci/dji314
Cryopreserved Archives | BioLife Solutions
Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and ... Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine. Immunotherapy ... neck cancer patients. Sampath, Won, Massarelli, Li, Frankel, Vora, Maghami, Kortylewski. Combined modality radiation therapy ... Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine. Hardin, ...https://www.biolifesolutions.com/tag/cryopreserved/
Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-Cell...
... that systemic virotherapy combined with antigen-expressing VSV could be used to support and enhance clinical immunotherapy ... RXRA and PPARG in Bladder Cancer. *. Design of Potent Prodrug Nanoassemblies for Cancer Therapy ... virotherapy offers the potential to treat tumors both as a single agent and in combination with traditional modalities such as ... Cancer Research Online ISSN: 1538-7445. Cancer Research Print ISSN: 0008-5472. Journal of Cancer Research ISSN: 0099-7013. ...http://cancerres.aacrjournals.org/content/early/2012/09/06/0008-5472.CAN-12-0600
Hyperthermia and immunotherapy in the treatment of cancer: the Gorter Model. - Free Online Library
... general Cancer Care and treatment Methods Patient outcomes Cancer treatment Fever Physiological aspects Immunotherapy ... Hyperthermia and immunotherapy in the treatment of cancer: the Gorter Model.(Clinical report) by 'Townsend Letter'; Health, ... Combining any of these therapies with localized hyperthermia appears to increase effectiveness, with fewer side effects. ... First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients ...https://www.thefreelibrary.com/Hyperthermia+and+immunotherapy+in+the+treatment+of+cancer%3A+the+Gorter...-a0303012900
Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological...
Combined modality therapy of advanced nodular lymphomas (NL): the role of nonspecific immunotherapy (MBV) as an important ... In addition to modern antigen-specific antibody- and vaccine-based immunologic cancer therapies, "nonspecific" immunotherapies ... This study was supported by the Cancer Vaccine Collaborative of the Cancer Research Institute, the Ludwig Institute for Cancer ... 2 with prostate cancer; 1 with head and neck cancer and 1 patient with bladder cancer. Two patients had resected disease at ...http://clincancerres.aacrjournals.org/content/18/19/5449?rss=1
Immunotherapy of Hepatocellular Carcinoma by Induction of Anti-alpha Fetoprotein Response
Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC ... All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery Endocrinology ... The purpose of this study is to choose the preferred treatment modality for solitary, small hepatocellular carcinoma. ... Immunotherapy of Hepatocellular Carcinoma With Gamma Delta T Cells. For most patients with hepatocellular carcinoma, surgery or ...https://www.bioportfolio.com/resources/trial/64671/Immunotherapy-of-Hepatocellular-Carcinoma-by-Induction-of-Anti-alpha-Fetoprotein-Response.html
Colorectal Cancer | OncoLink
... cancer treatments, cancer research advances, continuing medical education, cancer prevention, and clinical trials ... the Web's first cancer resource,provides comprehensive information on coping with cancer, ... Combined modality, post-operative adjuvant chemoradiation is considered the standard, as studies clearly demonstrate superior ... Emerging strategies in radiation therapy for colorectal cancer: intraoperative and stereotactic radiation therapy. Colorectal ...https://www.oncolink.org/healthcare-professionals/oncolink-university/general-oncology-courses/md2b-core-courses/md2b-solid-tumors/colorectal-cancer
Effective Combination of Chemotherapy and Dendritic Cell Administration for the Treatment of Advanced-Stage Experimental Breast...
... points to cancer immunotherapy as a modality that may potentially broaden the treatment of patients with cancer. These findings ... Next we tested antitumor effect of the combined therapy on parental cell line DA3. The groups of mice and treatment regimen ... Shah M. A., Schwartz G. K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin. Cancer Res., 7: ... Oliver R. T., Nouri A. M. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer ...http://clincancerres.aacrjournals.org/content/9/1/285
Download our free solidary book to support research on VHL disease